Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of remimazolam besylate for loss of consciousness in gynecological day surgery
ChiCTR2100052647Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam, sponsored by Weifang People's Hospital. Primary endpoint: Loss of consciousness. Started Nov 2021; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100052647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052647.